Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.38 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6723824 | 0.89 | TAAR1 (0.39) | CES1ALDH1A1PSMB5SMN1; SMN2MEN1 | |
| SCHEMBL6723970 | 0.89 | TAAR1 (0.39) | CES1ALDH1A1PSMB5SMN1; SMN2MEN1 | |
| SCHEMBL6723985 | 0.89 | TAAR1 (0.39) | CES1ALDH1A1PSMB5SMN1; SMN2MEN1 | |
| SCHEMBL13826147 | 0.89 | TAAR1 (0.39) | CES1ALDH1A1PSMB5SMN1; SMN2MEN1 | |
| SCHEMBL6723411 | 0.88 | PTPN1 (0.42) | CES1ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL27498154 | 0.86 | PTPN1 (0.41) | CES1ALDH1A1LMNASMN1; SMN2MEN1 | |
| SCHEMBL279361 | 0.85 | ALDH1A1 (0.41) | CES1ALDH1A1CYP2C19PSMB5SMN1; SMN2 | |
| SCHEMBL20800839 | 0.85 | CES1 (0.40) | CES1ALDH1A1TSHRCYP2C19LMNA | |
| SCHEMBL6723582 | 0.85 | CHKA (0.41) | CES1ALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL6780136 | 0.84 | CES1 (0.46) | CES1ALDH1A1TSHRLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11177446-B2 | Silicon containing organic fluorescent materials | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2021-11-16 | — | — | US | disclosed |
| US-20190081253-A1 | SILICON CONTAINING ORGANIC FLUORESCENT MATERIALS | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2019-03-14 | — | — | US | disclosed |
| EP-2802594-B1 | METAL COMPLEXES WITH DIBENZO[F,H]QUINOXALINES | UDC IRELAND LTD (IE) | 2017-04-19 | — | — | EP | disclosed |
| EP-0891121-B1 | ORGANIC ELECTROLUMINESCENT ELEMENTS | TDK CORP (JP) | 2012-09-26 | — | — | EP | disclosed |
| EP-1972619-B1 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LAB (JP) | 2012-08-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11177446-B2 | Silicon containing organic fluorescent materials | ORAI2, TRPA1, IK | CES1 3785/4885ALDH1A1 381/4885TSHR 4735/4885 |
| US-20190081253-A1 | SILICON CONTAINING ORGANIC FLUORESCENT MATERIALS | ORAI2, TRPA1, IK | CES1 3785/4885ALDH1A1 381/4885TSHR 4735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.